NES and cancer: Although PARD3 expression is differentially regulated in human cancers, and PARD3 may function as either an oncogene or tumour suppressor depending on cancer subtype or stage [22], a recent study showed that in human glioblastoma, PARD3 was enriched in NESTIN-positive stem cells.